RxDoctor Payments Data

Ami Shah

Pediatric Hematology-Oncology · Palo Alto, CANPI 1245321595

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,164 of the $4,683 with a category attached, or 88.9%. Vertex accounts for 88.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $3,638 and has fallen 97.8% since, to $80 in 2025.

$4,683in general payments, 2019–2025

Across 11 payments — averaging $425.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$4K
  • Genetix Biotherapeutics Inc$222
  • Sobi, Inc$185
  • Pharming Healthcare, Inc.$80
  • ADMA Biomanufacturing LLC$42
$3,185,223in research payments, 2019–2025

Across 26 payments — averaging $122,509 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$2.8M
  • Genetix Biotherapeutics Inc$345K
  • Hoffmann-la Roche Limited$584

What the payments were for

  • Consulting fees$4,16489%
  • Food & beverage$3608%
  • Education$1593%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,683 in reported general payments places this provider in the 70th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California

Other pediatric hematology-oncology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →